The test is an agglutination assay where patient serum is mixed with killed Proteus OX strains (OX2, OX19, and OXK). If antibodies against rickettsial bacteria are present in the patient’s serum, they will cross-react with the Proteus antigens, causing visible agglutination. Each strain of Proteus is used to detect different types of rickettsial infections.
